Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Gabriele RoccuzzoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7126-5506
Nicole MacagnoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0097-2139
Pietro GrignaniDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Chiara AstruaDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Matteo Giovanni BrizioDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Giovanni CavaliereDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Franco PicciottoDepartment of Surgery, Dermatologic Surgery Section, Azienda Ospedaliera Universitaria (AOU) Città della Salute e della Scienza, 10126 Turin, Italy.
Virginia CaliendoDepartment of Surgery, Dermatologic Surgery Section, Azienda Ospedaliera Universitaria (AOU) Città della Salute e della Scienza, 10126 Turin, Italy.
Enrico FrutteroDepartment of Surgery, Dermatologic Surgery Section, Azienda Ospedaliera Universitaria (AOU) Città della Salute e della Scienza, 10126 Turin, Italy.ORCID 0009-0003-2310-0346
Simone RiberoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0098-1406
Paolo FavaDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-8443-7458
Pietro QuaglinoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
adjuvant therapyimmunotherapylymphadenectomylymph node dissectionmelanomastage III melanomatargeted therapy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Treatment Patterns and Outcomes of Stage III Melanoma Patients with Positive Sentinel Lymph Node Biopsy: A Real-Life Experience. · full record | OpenQuestion